产品名称： 替西罗莫司(替西莫司)
英文名： Temsirolimus(CCI-779)
别名： NSC-683864;Torisel;Rapamycin 42-[3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate
化学名称： (1R,2R,4S)-4-{(2R)-2-[(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-1,5,11,28,29-pentaoxo-1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31,32,33,34,34a-tetracosahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontin-3-yl]propyl}-2-methoxycyclohexyl 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate
CAS No. ： 162635-04-3
分子式： C56H87NO16
分子量： 1030.29
外观： White to Off-White Solid
溶解性： Soluble in chloroform, water, DMSO and ethano
纯度： >99%
Usage: Temsirolimus (also known as CCI-779) is a recently developed mTOR inhibitor;Temsirolimus has shown promising preclinical and early clinical antitumor activity and is currently in phase III clinical development for the treatment of different solid tumors, including breast cancer.